CAS 79831-76-8 | CELG-001 : Celgosivir
(World's Largest Pharmaceutical Supplier)
- CAS Number: 79831-76-8
- Stock: 999g
- Assay: 0.00%
CAS 79831-76-8 is a chemical compound known as montelukast sodium. It is a medication that belongs to the class of leukotriene receptor antagonists and is primarily used for the treatment of asthma and allergic rhinitis.
Montelukast sodium is a white to off-white powder that is soluble in water. Its chemical formula is C35H34ClNO3SNa, and it is available in tablet or oral granule form for oral administration.
One of the main uses of CAS 79831-76-8 is in the management of asthma. Montelukast sodium works by blocking the action of leukotrienes, which are chemicals in the body that cause inflammation and constriction of the airways. By inhibiting leukotriene receptors, it helps to reduce bronchoconstriction, inflammation, and mucus production, leading to improved asthma control and symptom relief.
Additionally, montelukast sodium is prescribed for the treatment of allergic rhinitis, a condition characterized by inflammation of the nasal passages due to allergen exposure. It can help relieve symptoms such as sneezing, runny nose, itching, and congestion by reducing inflammation in the nasal mucosa.
Furthermore, montelukast sodium may be used as an add-on therapy in the prevention of exercise-induced bronchoconstriction, a condition where physical activity triggers asthma symptoms. By taking montelukast prior to exercise, individuals with exercise-induced bronchoconstriction can experience improved lung function and reduced symptoms during physical exertion.
It is important to note that montelukast sodium should be taken as prescribed by a healthcare provider. Common side effects may include headache, gastrointestinal disturbances, and upper respiratory tract infections. Rare but serious side effects, such as mood or behavior changes, have been reported and should be monitored closely, especially in children.
In conclusion, CAS 79831-76-8, or montelukast sodium, is a medication used in the treatment of asthma and allergic rhinitis. It helps to control airway inflammation, reduce bronchoconstriction, and provide symptom relief. However, it should be used as directed by a healthcare provider, and patients should be aware of potential side effects. Regular monitoring and adherence to an appropriate asthma management plan are crucial for optimal outcomes.